AstraZeneca Takes Out Antibiotic Firm Novexel, With Cash Back from Forest

AZ will pay up to $505 million and split antibiotic cocktail rights with Novexel partner Forest, which in turn will pay more than $200 million to AZ.

More from Archive

More from Pink Sheet